Winkel, Per
Jakobsen, Janus Christian
Hilden, Jørgen
Jensen, Gorm
Kjøller, Erik
Sajadieh, Ahmad
Kastrup, Jens
Kolmos, Hans Jørn
Larsson, Anders
Ärnlöv, Johan
Gluud, Christian
Clinical trials referenced in this document:
Documents that mention this clinical trial
High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR Trial
https://doi.org/10.3109/00365513.2010.538081
Prognostic value of 12 novel cardiological biomarkers in stable coronary artery disease. A 10-year follow-up of the placebo group of the Copenhagen CLARICOR trial
https://doi.org/10.1136/bmjopen-2019-033720
Osteoprotegerin independently predicts mortality in patients with stable coronary artery disease: The CLARICOR trial
https://doi.org/10.3109/00365513.2014.930510
Agreement between public register and adjudication committee outcome in a cardiovascular randomized clinical trial
https://doi.org/10.1016/j.ahj.2013.12.032
Prognostic value of routinely available data in patients with stable coronary heart disease. A 10-year follow-up of patients sampled at random times during their disease course
https://doi.org/10.1136/openhrt-2018-000808